Czechia· CZ-0290020
BIMERVAX LP.8.1
A covid-19, protein-untereinheit product containing sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion homodimer (omicron lp.8.1 - lp.8.1 strain), registered in Czechia by Hipra Human Health, S.L.U., Amer. The same ATC class is registered in 10 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Covid-19, protein-untereinheit is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BN04 (covid-19, protein-untereinheit), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 6 of them publish a price we can compare per daily dose
Covid-19, protein-untereinheit · ATC J07BN04
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- SARS-COV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER (OMICRON LP.8.1 - LP.8.1 STRAIN)
- Manufacturer
- Hipra Human Health, S.L.U., Amer
- Country
- Czechia (CZ)
- ATC code
- J07BN04
- ATC class
- Covid-19, Protein-Untereinheit
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BN04
Covid-19, protein-untereinheit, as other registers publish it.
- BelgiumBimervaxHipra Human Health
- PolandBimervaxHipra Human Health, S.L.U.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- IcelandBIMERVAXHipra Human Health S.L.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- FinlandBIMERVAXHipra Human Health S.L.
- DenmarkBIMERVAXHipra Human Health S.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea1fe6e9-7866-47a9-a2ae-6f6b5bf4da66 GET /v1/drugs/ea1fe6e9-7866-47a9-a2ae-6f6b5bf4da66?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ EML",
"source": "sukl",
"strength": null,
"pack_size": "10X0,5ML",
"substance": "SARS-COV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER (OMICRON LP.8.1 - LP.8.1 STRAIN)",
"cz_kod_sukl": "0290020",
"product_type": "IM/BT",
"substance_codes": "23487",
"registration_state": "R",
"registration_number": "EU/1/22/1709/008"
}See everything about covid-19, protein-untereinheit.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.